<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               11 DESCRIPTION<BR>               <BR>                  Letrozole tablets for oral administration contains 2.5 mg of <BR>letrozole, a non-steroidal aromatase inhibitor (inhibitor of estrogen <BR>synthesis). It is chemically described as 4,4'-(1H-1,2,4-triazol-1-ylmethylene)dibenzonitrile, and its <BR>structural formula is: <BR><BR>                  <BR>                  <BR>                     <BR>                  <BR>                  Letrozole, USP is a white to off-white powder, freely soluble in <BR>dichloromethane, slightly soluble in ethanol and practically insoluble in water. <BR>It has a molecular weight of 285.31, molecular formula C17H11N5, and a <BR>melting range of 184°C to 185°C. <BR>                  Letrozole tablets, USP are available as 2.5 mg tablets for oral <BR>administration. Each tablet contains the following inactive ingredients: <BR>colloidal silicon dioxide, D&C Red No. 27 Aluminum Lake, FD&C Blue No. 2 <BR>Aluminum Lake, FD&C Red No. 40 Aluminum Lake, hypromellose, lactose <BR>anhydrous, magnesium stearate, microcrystalline cellulose, polydextrose, <BR>polyethylene glycol, pregelatinized starch, sodium lauryl sulfate, sodium starch <BR>glycolate, titanium dioxide and triacetin.<BR>               <BR>               <BR>               <BR>                  <BR>                     image of chemical structure<BR>                     <BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>